TTY Biopharm announced unaudited consolidated earnings results for the month and year to date ended December 2016. For the month, the company posted a consolidated net sales of TWD 326,498,000, a consolidated operating profit of TWD 50,140,000, and a consolidated income before tax of TWD 90,090,000, net income attributed to stockholders of the company of TWD 29,860,000 which contributed to an EPS of TWD 0.12. For the year-to-date, the company announced consolidated net sale was TWD 3,762,580,000, a consolidated operating profit was TWD 1,193,480,000, and a consolidated income before tax was TWD 1,531,655,000 and net income attributed to stockholders of the company was TWD 1,216,826,000 which contributed to an accumulated EPS of TWD 4.89.